Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-25-326984
Filing Date
2025-12-19
Accepted
2025-12-19 16:44:13
Documents
17

Document Format Files

Seq Description Document Type Size
1 F-1 d45363df1.htm F-1 790447
2 EX-5.1 d45363dex51.htm EX-5.1 385910
3 EX-23.1 d45363dex231.htm EX-23.1 1855
4 EX-FILING FEES d45363dexfilingfees.htm   iXBRL EX-FILING FEES 18725
5 GRAPHIC g45363g05r77.jpg GRAPHIC 63325
6 GRAPHIC g45363snap1.jpg GRAPHIC 15067
7 GRAPHIC g45363snap2.jpg GRAPHIC 6393
  Complete submission text file 0001193125-25-326984.txt   1438334

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d45363dexfilingfees_htm.xml XML 5379
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1 | Act: 33 | File No.: 333-292303 | Film No.: 251588167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)